New Bone Biopsy Study Confirms Unique Dual Mode Of Action and Bone Safety of Protelos® (Strontium Ranelate) in Osteoporosis Treatment

... New results presented at the annual American Society of Bone and Mineral Research (ASBMR) meeting today confirm the unique approach to postmenopausal osteoporosis treatment offered by a new therapy, Protelos® / Protos® (strontium ranelate, Servier). The new data, based on bone biopsies, provide scientific proof that the novel anti-osteoporotic agent has a dual mechanism of action that is completely different from existing treatments and confirm its long term bone safety... click link for more info. ...